Neutralizing human monoclonal antibodies specific for the v3...

Details Neutralizing human monoclonal antibodies specific for the v3... Neutralizing human monoclonal antibodies specific for the v3...

C - Chemistry, Metallurgy

12

N

C12N 5/10 (2006.01) A61K 39/21 (2006.01) A61K 39/42 (2006.01) A61K 47/48 (2006.01) C07K 14/16 (2006.01) C07K 16/10 (2006.01) G01N 33/569 (2006.01) G01N 33/577 (2006.01) A61K 38/00 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2094713

2094713 9207878 PCTABS00013 Anti-HIV-1 antibodies directed against the V3 loop and the CD-4 binding site of gp120 synergistically neutralize. Certain antibodies neutralize the IIIB, MN, SF-2 and RF strains.

Affiliated with

Also associated with

Rating

Neutralizing human monoclonal antibodies specific for the v3... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Neutralizing human monoclonal antibodies specific for the v3..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neutralizing human monoclonal antibodies specific for the v3... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1564968